High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation

Preston Dennett1, Lohra M Young2, Benjamin E Draper2

  • 1NanoEngineering Corporation, New Haven, CT, USA.

Gene Therapy
|June 4, 2026
PubMed
Summary

High-resolution electrospray differential mobility analysis (ES-DMA) accurately sizes recombinant adeno-associated virus (rAAV) particles. This novel method distinguishes empty, full, and partial rAAV capsids, improving gene therapy manufacturing quality control.

Related Concept Videos